Origent Data Sciences and Cytokinetics Advance Collaboration Intended to Validate Predictive Analytics Model in ALS
AND SOUTH SAN FRANCISCO, Calif., March 23, 2017-- Origent Data Sciences, Inc. and Cytokinetics, Inc. today announced the advancement of their research collaboration to prospectively validate Origent’ s ...
- Investopedia•2 days ago
Cytokinetics' spinal muscular atrophy drug, CK-2127107, improved muscle function in a pre-clinical study.
- GlobeNewswire•2 days ago
SOUTH SAN FRANCISCO, Calif., March 22, 2017-- Cytokinetics, Inc. today announced that preclinical data for CK-2127107 were presented at the MDA Scientific Conference in Arlington, VA, showing that this ...
CYTK : Summary for Cytokinetics, Incorporated - Yahoo Finance
Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||12.85 x 200|
|Ask||12.90 x 800|
|Day's Range||12.60 - 13.20|
|52 Week Range||6.31 - 13.70|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||33.01|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|